PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-77.16%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-68.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-107.08%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-105.50%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-126.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-126.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-126.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.85%
Negative 10Y revenue/share CAGR while 5715.T stands at 36.90%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-86.85%
Negative 5Y CAGR while 5715.T stands at 36.90%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-86.85%
Negative 3Y CAGR while 5715.T stands at 36.90%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
92.83%
Similar net income/share CAGR to 5715.T's 103.05%. Walter Schloss would see parallel tailwinds or expansions for both firms.
92.83%
5Y net income/share CAGR similar to 5715.T's 103.05%. Walter Schloss might see both on parallel mid-term trajectories.
92.83%
3Y net income/share CAGR similar to 5715.T's 103.05%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while 5715.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
114.13%
Inventory growth well above 5715.T's 1.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.84%
Positive asset growth while 5715.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-10.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
19.17%
Debt growth far above 5715.T's 0.25%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.